Phuong N. Huynh

Array ( [id] => 11737180 [patent_doc_number] => 09701753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-11 [patent_title] => 'Hyperglycosylated binding polypeptides' [patent_app_type] => utility [patent_app_number] => 14/203438 [patent_app_country] => US [patent_app_date] => 2014-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 35 [patent_no_of_words] => 28919 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14203438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10662340 [patent_doc_number] => 20160008484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'IMPROVED PREPARATION METHOD FOR HIGH-YIELD PRODUCTION OF PHYSIOLOGICALLY ACTIVE POLYPEPTIDE CONJUGATE' [patent_app_type] => utility [patent_app_number] => 14/772493 [patent_app_country] => US [patent_app_date] => 2014-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9965 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14772493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9685315 [patent_doc_number] => 20140242079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES' [patent_app_type] => utility [patent_app_number] => 14/188486 [patent_app_country] => US [patent_app_date] => 2014-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 49344 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14188486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9685316 [patent_doc_number] => 20140242080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES' [patent_app_type] => utility [patent_app_number] => 14/188516 [patent_app_country] => US [patent_app_date] => 2014-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 137 [patent_figures_cnt] => 137 [patent_no_of_words] => 74045 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14188516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9685318 [patent_doc_number] => 20140242082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/186149 [patent_app_country] => US [patent_app_date] => 2014-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 32332 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14186149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10483333 [patent_doc_number] => 20150368352 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-24 [patent_title] => 'NOVEL MULTISPECIFIC CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 14/765861 [patent_app_country] => US [patent_app_date] => 2014-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17553 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14765861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10721205 [patent_doc_number] => 20160067351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-10 [patent_title] => 'SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/764026 [patent_app_country] => US [patent_app_date] => 2014-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 55474 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14764026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10491276 [patent_doc_number] => 20150376297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'METHOD FOR REFOLDING ANTIBODY, PROCESS FOR PRODUCING REFOLDED ANTIBODY, REFOLDED ANTIBODY, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/767373 [patent_app_country] => US [patent_app_date] => 2014-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17584 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9812007 [patent_doc_number] => 20150023951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'ANTI-VEGF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/171616 [patent_app_country] => US [patent_app_date] => 2014-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 30375 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14171616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9510891 [patent_doc_number] => 20140147382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'IMMUNOTHERAPY OF B CELL MALIGNANCIES AND AUTOIMMUNE DISEASES USING UNCONJUGATED ANTIBODIES AND CONJUGATED ANTIBODIES AND ANTIBODY COMBINATIONS AND FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 14/168710 [patent_app_country] => US [patent_app_date] => 2014-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13190 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14168710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11537847 [patent_doc_number] => 09612247 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-04 [patent_title] => 'Methods for optimizing domain stability of binding proteins' [patent_app_type] => utility [patent_app_number] => 14/161552 [patent_app_country] => US [patent_app_date] => 2014-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9967 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 607 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14161552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12486831 [patent_doc_number] => 09993548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-12 [patent_title] => Tolerogenic synthetic nanocarriers for inducing regulatory B cells [patent_app_type] => utility [patent_app_number] => 14/161660 [patent_app_country] => US [patent_app_date] => 2014-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 30262 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14161660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9568668 [patent_doc_number] => 20140186381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'EPITOPE PEPTIDES DERIVED FROM VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1 AND VACCINES CONTAINING THESE PEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/160436 [patent_app_country] => US [patent_app_date] => 2014-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10345 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14160436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11210944 [patent_doc_number] => 09439961 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-13 [patent_title] => 'Pharmaceutical composition for treating ischemic events' [patent_app_type] => utility [patent_app_number] => 14/151507 [patent_app_country] => US [patent_app_date] => 2014-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 12331 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14151507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10974234 [patent_doc_number] => 20140377269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'MULTIVALENT ANTIBODY ANALOGS, AND METHODS OF THEIR PREPARATION AND USE' [patent_app_type] => utility [patent_app_number] => 14/135286 [patent_app_country] => US [patent_app_date] => 2013-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 42993 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14135286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10932054 [patent_doc_number] => 20140335075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS' [patent_app_type] => utility [patent_app_number] => 14/109384 [patent_app_country] => US [patent_app_date] => 2013-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 40705 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14109384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9408002 [patent_doc_number] => 20140099254 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'COMBINATION THERAPY FOR INDUCING IMMUNE RESPONSE TO DISEASE' [patent_app_type] => utility [patent_app_number] => 14/106737 [patent_app_country] => US [patent_app_date] => 2013-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 53161 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14106737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10641458 [patent_doc_number] => 09358309 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-07 [patent_title] => 'Radioimunoconjugates and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/100756 [patent_app_country] => US [patent_app_date] => 2013-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10097 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14100756 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9596726 [patent_doc_number] => 20140193407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-10 [patent_title] => 'DRUG FUSIONS AND CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/099210 [patent_app_country] => US [patent_app_date] => 2013-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 25055 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14099210 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10414298 [patent_doc_number] => 20150299307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'ANTI-VEGF ANTIBODIES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 14/648385 [patent_app_country] => US [patent_app_date] => 2013-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 40483 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14648385 [rel_patent_id] =>[rel_patent_doc_number] =>)